Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Clinical trial NCT07399678 · RECRUITING

Trial details

NCT number: NCT07399678
Sponsor: Alveus Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight or Obese Adults Overweight or Obese, Type 2 Diabetes

Start date: 2025-12-29
Primary completion: 2027-04-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.